| 1 day | -16.59% |
| Manager | Title | Age | Since |
|---|---|---|---|
Carl Merton
CEO | Chief Executive Officer | 57 | 21/06/2023 |
Pamela McRae
CTO | Chief Tech/Sci/R&D Officer | - | - |
Richard Redekop
COO | Chief Operating Officer | - | 14/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Chiara
BRD | Director/Board Member | - | 03/11/2016 |
Peter Montour
BRD | Director/Board Member | - | 29/08/2021 |
William Montour
BRD | Director/Board Member | - | 04/01/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/05/23 | Other | Director | 0 | 0% | ||
| 28/04/23 | Option | Director | 8,117 | 0.0189% | ||
| 28/04/23 | Tax | Chief Executive Officer | 3,184,422 | 7.4181% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -16.59% | -39.87% | - | - | 29.39M | ||
| +1.94% | +0.66% | +0.96% | -12.60% | 2.6B | ||
| +2.00% | +3.71% | +33.41% | +103.04% | 2.26B | ||
| 0.00% | +1.15% | -43.97% | +116.81% | 525M | ||
| -3.64% | -7.02% | -13.82% | -11.67% | 58.25M | ||
| Average | -3.26% | -0.38% | -5.86% | +48.90% | 1.36B | |
| Weighted average by Cap. | +1.62% | +1.89% | +9.94% | +47.89% |
Employees
-
Sector
Pharmaceuticals
















